Cold Contact Urticaria
Dermatology
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
1
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Faes FarmaBilastine
RegeneronRilonacept
Clinical Trials (2)
Total enrollment: 40 patients across 2 trials
Bilastine Updosing - Characterization of Underlying Mechanisms
Start: Sep 2010Est. completion: Dec 201120 patients
Phase 2/3Completed
Cold Contact Urticaria Treatment With Rilonacept
Start: Jan 2015Est. completion: May 201820 patients
Phase 2Completed
Related Jobs in Dermatology
MSL/Senior MSL, Dermatology - Tampa, Florida
AbbVie
Remote
10h ago
(Senior) Außendienstmitarbeiter Dermatology (all genders) - Region Thüringen
AbbVie
Remote
10h ago
Regional Sales Trainer - Dermatology (Central / West Regions)
AbbVie
Remote
11h ago
Regional Sales Trainer - Dermatology (Northeast / Southeast Regions)
AbbVie
Remote
11h ago
Delegado Especialista Ventas Dermatología (Inmunología)
AbbVie
Remote
15h ago
Senior Manager, HTA, Value and Evidence (HV&E), Medical Dermatology
Pfizer
United States - New York - New York City
Yesterday
$139K - $232K/yr
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space